Parrish GalliherCTO - Upstream at GE Healthcare Life Sciences
Mr. Galliher earned his BA in Biology at Boston University (1975) and MS degree in Biochemical Engineering at MIT (1981) after which he held technical management positions at Biogen, Inc., Alpha-Beta Technology, LeukoSite, and Millennium Pharmaceuticals. Mr. Galliher helped build and lead development, manufacturing and CMC teams who developed scalable bioprocesses, built biomanufacturing facilities, and achieved commercial licensure of Avonex™ (beta-interferon) and CAMPATH™ monoclonal antibody. In 2002 he became Founder, President and CEO of Xcellerex Inc., a single use technology/services company, at which he led the creation and commercialization of the single use (SU) XDR™ mammalian and microbial bioreactor, XDM™ and XDUO SU mixing systems and the turnkey SU modular FlexFactory® biomanufacturing platform. In 2012 Xcellerex was acquired by GE Healthcare at which Mr. Galliher continues as Chief Technology Officer, Upstream. In 2012 Mr. Galliher was awarded Bioprocess International’s 2012 “Thought Leader of the Decade, Upstream”. Mr. Galliher has dedicated his career to the potential of biotechnology to transform human health, and is a co-inventor of numerous patented inventions in the field of advanced, high efficiency biomanufacturing technologies.